Pharmaceutical Headlines for 19 may 2011 ( Thursday ) !

Pharmaceutical Headlines for 19 may 2011 ( Thursday )

• Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Wraps Up Nycomed for $13.7 Billion, Skin Unit to Spin Off More... 

• Thermo Fisher Scientific (TMO) to Acquire Phadia AB for $3.5 Billion Cash More...

 

• Celldex Therapeutics, Inc. (CLDX) Raises $31.5 Million More...

 

• Biotech Firm, Gallus Biopharmaceuticals to Add 160 Jobs In Missouri More...

• AstraZeneca PLC (AZN) Drug Slows Ovarian Cancer Progression in Phase 2 Study More... 

• Exelixis, Inc. (EXEL) Pill Slows Prostate Cancer and Ovarian Tumors in Study More... 

• Pfizer Inc. (PFE) Presents New Phase 3 Data Showing Axitinib Significantly Extended Progression-Free Survival Compared With Sorafenib In Patients With Previously-Treated Advanced Renal Cell Carcinoma More...

 

• Enzon Pharmaceuticals, Inc. (ENZN) Ditches PEG-SN38 for mCRC but Continues Development in Other Cancers More...

• O.C. Heart Device Firm Raises $107 Million More... 

• Baxter Canada Slashes 135 Jobs, Closes Sherbrooke, Quebec, Plant More...

• Thermo Fisher Scientific (TMO) to Acquire Phadia AB for $3.5 Billion Cash More... 

• Maquet Cardiovascular LLC Receives 510(k) Clearance and CE Mark for CARDIOROOT More...

• Abbott Laboratories (ABT) Receives FDA Approval for Molecular Test for Hepatitis C More...

( Source: Biospace )

Posted in: Pharma Hub